CTI BioPharma Corp (CTIC) is around the top of the Biotechnology industry according to InvestorsObserver. CTIC received an overall rating of 87, which means that it scores higher than 87 percent of all stocks. CTI BioPharma Corp also achieved a score of 97 in the Biotechnology industry, putting it above 97 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 87 would rank higher than 87 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With CTI BioPharma Corp Stock Today?
CTI BioPharma Corp (CTIC) stock is trading at $3.49 as of 1:17 PM on Wednesday, Feb 10, a decline of -$0.19, or -5.16% from the previous closing price of $3.68. The stock has traded between $3.41 and $3.73 so far today. Volume today is 611,628 compared to average volume of 602,803.
Click Here to get the full Stock Score Report on CTI BioPharma Corp (CTIC) Stock.
